Klinrisk provides AI‑enabled laboratory services that automatically interpret routine test results and deliver actionable decision‑support recommendations for chronic disease management. By leveraging large population health data, its platform helps providers personalize care for conditions such as cardiovascular, renal, and metabolic diseases, improving medication use, therapy planning, and reducing adverse events.
Funding
Funding not disclosed
Founders
Product
Problem
Standard laboratory tests are routinely performed but their results are often presented without personalized interpretation or clear clinical guidance, leaving clinicians to manually analyze data and decide next steps for chronic disease management.
Solution
Klinrisk provides an AI‑enabled laboratory service that processes routinely collected lab results and generates individualized decision‑support reports. By leveraging large, bias‑controlled population health datasets, the platform produces personalized risk assessments and specific treatment recommendations for conditions such as cardiovascular, renal, and metabolic diseases. The output integrates into existing clinician workflows via APIs, portals, and reports, reducing the time needed for result interpretation and helping providers make evidence‑based medication and therapy decisions. This automated insight aims to improve medication appropriateness, therapy planning, and reduce adverse events, ultimately extending patients’ independent living.
Target Audience
Primary customers are healthcare providers, laboratories, hospitals, and other institutional partners that manage patients with chronic cardiovascular, renal, or metabolic conditions.
Features
- AI algorithms that transform raw lab values into risk scores and actionable clinical recommendations tailored to each patient
- Integration options including RESTful APIs, clinician portals, and downloadable reports for seamless incorporation into electronic health record systems
- Use of extensive, bias‑controlled population health data to ensure accurate, unbiased interpretations across diverse patient groups
- Automated alerts highlighting high‑risk results and suggested next‑step actions for providers
- Secure, HIPAA‑compliant data handling and encryption throughout the analytics pipeline